Wells Fargo analyst John Kilichowski lowered the firm’s price target on Healthpeak Properties (DOC) to $18 from $19 and keeps an Equal Weight rating on the shares. The firm recently toured the South SF Life Science market, which is 16msf. The company’s tone was positive but Wells estimates about 500bps of occ loss in Q4 and Q1 before the second half of 2026 expected ramp.
Claim 50% Off TipRanks Premium
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on DOC:
- Healthpeak Unveils Janus Living IPO and Portfolio Strategy
- Healthpeak Properties reports Q4 FFO 47c, consensus 45c
- Healthpeak Properties sees FY26 FFO $1.70-$1.74, consensus $1.84
- Physicians Realty Trust options imply 3.0% move in share price post-earnings
- The Week That Was, The Week Ahead: Macro and Markets, Feb. 1